Autopsy report · NCT04348656
CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)
Cause of deathFutility
“Study was terminated after the planned interim analysis as the pre-defined futility threshold was met”
Life of this trial
- Ran for about 1 year 3 months before it stopped.
- 940 participants enrolled.
- Results were posted on the registry 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Hamilton Health Sciences Corporation
- Sponsor type
- University, hospital or other
- Conditions
- COVID-19
- Interventions
- Convalescent plasma
- Participants
- 940
- Sites
- 73
- Countries
- Brazil, Canada, United States
Trials that died the same way
- Tissue Adhesive vs. Sterile Strips After Cesarean Delivery
“Based on results of an interim analysis, the study was halted for futility” - Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients
“The study was stopped for futility at the first interim analysis” - Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)
“Based on the outcome of a planned interim analysis, the study was stopped early due to futility.” - Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
“This study was terminated early due to futility.” - Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
“Study futility based on the interim analysis”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.